Agios Pharmaceuticals Inc (NASDAQ:AGIO)

91.67
Delayed Data
As of Mar 26
 -1.19 / -1.28%
Today’s Change
31.42
Today|||52-Week Range
138.85
-18.18%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Celgene Corp
Buy12/16/2014228,645$110.75$25.3M-14.70%
Biller Scott
Chief Scientific Officer
Sale9/19/201437,996$50.45$1.9M+87.43%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+43.77%
Schenkein David Paul
Chief Executive Officer
Sale9/26/201430,000$62.68$1.9M+43.77%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale2/09/201515,000$105.81$1.6M-13.49%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M-16.48%
Higgons John Duncan
Chief Operating Officer
Sale1/02/201512,000$110.08$1.3M-16.48%
Higgons John Duncan
Chief Operating Officer
Sale12/01/201412,000$97.03$1.2M-4.78%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale3/16/201510,000$106.24$1.1M-13.88%
Higgons John Duncan
Chief Operating Officer
Sale11/03/201413,000$81.71$1.1M+10.35%
Page of 13

To view my watchlist

Not a member yet?

Sign up now for a free account